Solara Active Pharma temporarily suspends production of Ranitidine Hydrochloride drug

Solara Active Pharma Sciences Ltd. | Pharmaceuticals & Drugs | Healthcare | BSE: 541540 | NSE: SOLARA

27 Sep 2019 Evaluate

Solara Active Pharma Sciences has temporarily suspended production and distribution of Ranitidine Hydrochloride drug substance. The Company has received request for information from USFDA and EDQM to provide test data on N-nitrosodimethylamine (NDMA) content in Ranitidine Hydrochloride drug substance. The Company is in the process of responding to the information request comprehensively by second week of October 2019.

Solara Active Pharma Sciences is a young, dynamic, entrepreneurial and customer oriented API manufacturer.

Peers

Company Name	CMP
Sun Pharma. Inds.	1846.70
Dr. Reddys Labs.	1200.90
Cipla	1404.35
Lupin	2086.45
Zydus Lifesciences	1197.30
View more..

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045

Compliance Officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com	Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com	Telephone: +919860919463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com	Telephone: +919175899463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.